Clinical Trials Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jun 14, 2019; 25(22): 2799-2808
Published online Jun 14, 2019. doi: 10.3748/wjg.v25.i22.2799
Figure 1
Figure 1 Flow diagram of the participants.
Figure 2
Figure 2 Difference in the Th17 and Treg lymphocyte percentages and the Th17/Treg cell ratios between the early enteral nutrition and delayed enteral nutrition groups. A: Difference in the Th17 lymphocyte percentages between the early enteral nutrition (EEN) and delayed enteral nutrition (DEN) groups; B: Difference in the Treg lymphocyte percentages between the EEN and DEN groups; C: Differences in the Th17/Treg cell ratios between the EEN and DEN groups. aP < 0.05. EEN: Early enteral nutrition; DEN: Delayed enteral nutrition.
Figure 3
Figure 3 Difference in the serum IL-17 and IL-23 levels and the IL-23/IL-17 ratios between the early enteral nutrition and delayed enteral nutrition groups. A: Difference in the serum IL-17 levels between the early enteral nutrition (EEN) and delayed enteral nutrition (DEN) groups; B: Difference in the serum IL-23 levels between the EEN and DEN groups; C: Difference in the IL-23/IL-17 ratios between the EEN and DEN groups. aP < 0.05. EEN: Early enteral nutrition; DEN: Delayed enteral nutrition.
Figure 4
Figure 4 Difference in the serum IL-6 and IL-10 levels between the early enteral nutrition and delayed enteral nutrition groups. A: Difference in the serum IL-6 levels between the early enteral nutrition (EEN) and delayed enteral nutrition (DEN) groups; B: Difference in the serum IL-10 levels between the EEN and DEN groups. aP < 0.05. EEN: Early enteral nutrition; DEN: Delayed enteral nutrition.
Figure 5
Figure 5 Survival curves for up to 28 days after admission between the early enteral nutrition and delayed enteral nutrition groups (P = 0. 728). EEN: Early enteral nutrition; DEN: Delayed enteral nutrition.